Chemistry
Deoxyribonucleic Acid
100%
Pyrrolobenzodiazepine
80%
1,4-benzodiazepine
47%
Synthesis (Chemical)
43%
Antineoplastic Agent
24%
Molecules
22%
Cytotoxic
16%
Ligand
15%
DNA Sequence
14%
dimer
14%
Kd
14%
formation
12%
Carboxamide
10%
Heterocyclic Compound
10%
Molecular dynamics simulation
9%
Liquid Chromatography Mass Spectrometry
9%
Circular Dichroism
8%
Melting Point
8%
Reactivity
7%
Application
7%
RNA
7%
Enol
7%
Microwave Irradiation
7%
Single-Stranded DNA
7%
Regiochemistry
7%
Biaryl
7%
Stille Coupling Reaction
7%
Benzodiazepine
7%
Quinoline
7%
Triflate
7%
Pharmacokinetics
7%
Hydrogen
6%
Denaturation
5%
Group
5%
Medicine and Dentistry
Antibody-Drug Conjugate
51%
DNA
45%
Dimer
21%
In Vitro
21%
Toxicity
15%
Breast Cancer
14%
Proteochondroitin Sulfate
14%
Melanoma
14%
DNA Binding
12%
Therapeutic Procedure
10%
Double Stranded DNA
10%
Pancreas Cancer
10%
Tumor Cell Line
9%
Hematological Cancer
9%
B-Cell Chronic Lymphocytic Leukemia
9%
Clinical Trial
8%
Cancer Cell Line
8%
Monomer
8%
Xenograft
7%
Antineoplastic Activity
7%
Topical Treatment
7%
Bortezomib
7%
Ligand Binding
7%
Antiproliferative Activity
7%
Actinic Keratosis
7%
Cytotoxic Agent
7%
DNA Fragment
7%
Ibrutinib
7%
Guanine Quadruplex
7%
Epidermal Growth Factor Receptor
7%
Triple Negative Breast Cancer
7%
Cancer Growth
7%
Cyclin-Dependent Kinase
7%
Homologous Recombination
7%
Mammalian Cell
7%
Endonuclease
7%
Mechanism of Action
6%
Leukemia Cell
5%
DNA Base
5%
Selectivity
5%
Neoplasm
5%
Therapeutics
5%
Tumor Xenograft
5%
Liquid Chromatography-Mass Spectrometry
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antibody Drug Conjugate
76%
Antitumor Activity
50%
Benzodiazepine
24%
Anthramycin
21%
Drug Discovery
17%
High Performance Liquid Chromatography
15%
Propylene Glycol
14%
Mouse Model
9%
Imine
8%
Prodrug
7%
Ether
7%
Polyamide
7%
Alkaloid
7%
Nuclear Factor Y
7%
Piperazinedione
7%
Eribulin
7%
Antibody Structure
7%
Enzyme Inhibition
7%
Phenylalkylamine
7%
Tetracycline Derivative
7%
Cyclin Dependent Kinase
7%
Scanning Electron Microscopy
7%
Structure Activity Relationship
7%
Gram Positive Bacterium
7%
Hydrophobicity
7%
Promyelocytic Leukemia
5%
Clinical Trial
5%